Movatterモバイル変換

[0]ホーム
URL:

WO2005037318A3 - Treatment of arthritic conditions, chronic inflammation or pain - Google Patents

Treatment of arthritic conditions, chronic inflammation or painDownload PDF

Info

Publication number
WO2005037318A3
WO2005037318A3PCT/US2004/034184US2004034184WWO2005037318A3WO 2005037318 A3WO2005037318 A3WO 2005037318A3US 2004034184 WUS2004034184 WUS 2004034184WWO 2005037318 A3WO2005037318 A3WO 2005037318A3
Authority
WO
WIPO (PCT)
Prior art keywords
pain
arthritic conditions
treatment
opioid antagonists
methods
Prior art date
Application number
PCT/US2004/034184
Other languages
French (fr)
Other versions
WO2005037318A2 (en
Inventor
Grant L Schoenhard
Nadav Friedmann
Original Assignee
Pain Therapeutics Inc
Grant L Schoenhard
Nadav Friedmann
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pain Therapeutics Inc, Grant L Schoenhard, Nadav FriedmannfiledCriticalPain Therapeutics Inc
Priority to AU2004281153ApriorityCriticalpatent/AU2004281153A1/en
Priority to CA002542395Aprioritypatent/CA2542395A1/en
Priority to EP04795362Aprioritypatent/EP1680143A2/en
Publication of WO2005037318A2publicationCriticalpatent/WO2005037318A2/en
Publication of WO2005037318A3publicationCriticalpatent/WO2005037318A3/en

Links

Classifications

Landscapes

Abstract

Methods and materials, including novel compositions, dosage forms and methods of administration, useful for treating arthritic conditions, inflammation associated with a chronic condition, and/or chronic pain, including pain from arthritis and inflammation, using opioid antagonists, including combinations of opioid antagonists and opioid agonists. Methods and materials comprising opioid antagonists or combinations opioid antagonists and agonists may optionally include one or more additional therapeutic agents.
PCT/US2004/0341842003-10-152004-10-15Treatment of arthritic conditions, chronic inflammation or painWO2005037318A2 (en)

Priority Applications (3)

Application NumberPriority DateFiling DateTitle
AU2004281153AAU2004281153A1 (en)2003-10-152004-10-15Treatment of arthritic conditions, chronic inflammation or pain
CA002542395ACA2542395A1 (en)2003-10-152004-10-15Treatment of arthritic conditions, chronic inflammation or pain
EP04795362AEP1680143A2 (en)2003-10-152004-10-15Treatment of arthritic conditions, chronic inflammation or pain

Applications Claiming Priority (4)

Application NumberPriority DateFiling DateTitle
US51184103P2003-10-152003-10-15
US60/511,8412003-10-15
US56618904P2004-04-272004-04-27
US60/566,1892004-04-27

Publications (2)

Publication NumberPublication Date
WO2005037318A2 WO2005037318A2 (en)2005-04-28
WO2005037318A3true WO2005037318A3 (en)2005-06-09

Family

ID=34468007

Family Applications (1)

Application NumberTitlePriority DateFiling Date
PCT/US2004/034184WO2005037318A2 (en)2003-10-152004-10-15Treatment of arthritic conditions, chronic inflammation or pain

Country Status (4)

CountryLink
EP (1)EP1680143A2 (en)
AU (1)AU2004281153A1 (en)
CA (1)CA2542395A1 (en)
WO (1)WO2005037318A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
EP1897544A1 (en)*2006-09-052008-03-12Holger Lars HermannOpioid agonist and antagonist combinations
CN118512454A (en)*2024-06-062024-08-20中国药科大学 Application of naltrexone in the preparation of drugs for treating hyperuricemia

Citations (9)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US4769372A (en)*1986-06-181988-09-06The Rockefeller UniversityMethod of treating patients suffering from chronic pain or chronic cough
US5472943A (en)*1992-09-211995-12-05Albert Einstein College Of Medicine Of Yeshiva University,Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other opioid agonists
WO1999032119A1 (en)*1997-12-221999-07-01Euro-Celtique, S.A.Opioid agonist/antagonist combinations
WO2001058447A1 (en)*2000-02-082001-08-16Euro-Celtique, S.A.Controlled-release compositions containing opioid agonist and antagonist
WO2001085150A2 (en)*2000-05-052001-11-15Pain Therapeutics, Inc.Opioid antagonist containing composition for enchaching the potency or reducing adverse side effects ofopioid agonists
WO2003013525A1 (en)*2001-08-062003-02-20Euro-Celtique S.A.Opioid agonist formulations with releasable and sequestered antagonist
US20030191147A1 (en)*2002-04-092003-10-09Barry ShermanOpioid antagonist compositions and dosage forms
US20040110781A1 (en)*2002-12-052004-06-10Harmon Troy M.Pharmaceutical compositions containing indistinguishable drug components
WO2004091593A2 (en)*2003-04-142004-10-28Pain Therapeutics, Inc.Methods for the treatment of pain comprising opioid antagonists

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US4769372A (en)*1986-06-181988-09-06The Rockefeller UniversityMethod of treating patients suffering from chronic pain or chronic cough
US5472943A (en)*1992-09-211995-12-05Albert Einstein College Of Medicine Of Yeshiva University,Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other opioid agonists
WO1999032119A1 (en)*1997-12-221999-07-01Euro-Celtique, S.A.Opioid agonist/antagonist combinations
WO2001058447A1 (en)*2000-02-082001-08-16Euro-Celtique, S.A.Controlled-release compositions containing opioid agonist and antagonist
WO2001085150A2 (en)*2000-05-052001-11-15Pain Therapeutics, Inc.Opioid antagonist containing composition for enchaching the potency or reducing adverse side effects ofopioid agonists
WO2003013525A1 (en)*2001-08-062003-02-20Euro-Celtique S.A.Opioid agonist formulations with releasable and sequestered antagonist
US20030191147A1 (en)*2002-04-092003-10-09Barry ShermanOpioid antagonist compositions and dosage forms
US20040110781A1 (en)*2002-12-052004-06-10Harmon Troy M.Pharmaceutical compositions containing indistinguishable drug components
WO2004091593A2 (en)*2003-04-142004-10-28Pain Therapeutics, Inc.Methods for the treatment of pain comprising opioid antagonists

Also Published As

Publication numberPublication date
AU2004281153A1 (en)2005-04-28
CA2542395A1 (en)2005-04-28
WO2005037318A2 (en)2005-04-28
EP1680143A2 (en)2006-07-19

Similar Documents

PublicationPublication DateTitle
WO2005107726A3 (en)Method for the treatment of back pain
WO2003070191A8 (en)Tamper-resistant transdermal opioid delivery devices
WO2004000354A3 (en)Method of treating the syndrome of lipodystrophy
DE602004005076D1 (en) COEXTRUDED SAFETY DOSAGE FORM WITH AN ACTIVE AGENT AND ADVERSE AGENT AND METHOD OF MANUFACTURING THEREOF
TW200631578A (en)Methods and compositions using immunomodulatory compounds for treatment and management of central nervous system injury
WO2005041925A3 (en)Compositions and dosage forms for enhanced absorption
BR0307508A (en) Compound, pharmaceutical composition, and methods of treating or preventing pain and inflammation and treating disease
BRPI0412557A (en) pharmaceutical dosage form of cardiovascular events
WO2002099388A3 (en)Benzodiazepine bradykinin antagonists
WO2004091540A3 (en)Methods of treating pain and compositions for use therefor
MXPA06000705A (en)Combination of mglur2 antagonist and ache inhibitor for treatment of acute and/or chronic neurological disorders.
MX2007006066A (en)Jnk inhibitors for treatment of cns injury.
WO2006036770A3 (en)Combination therapy for the treatment of obesity
WO2003094921A3 (en)Utilization of inhibitors of egfr-mediated signal transduction for the treatment of benign prostatic hyperplasia (bph)/prostatic hypertrophy
WO2007006732A8 (en)Synergistic combination for the treatment of pain (cannabioid receptor agonist and opiod receptor agonist)
MXPA06002722A (en)A pharmaceutical composition comprising a p2x7 receptor antagonist and a nonsteroidal anti inflammatory drug.
WO2006074265A3 (en)Drug combination therapy and pharmaceutical compositions for treating inflammatory disorders
MXPA05012358A (en)Pharmaceutical combination comprising modafinil and another drug.
ATE465735T1 (en) USE OF A COMBINATION OF MORPHINE AND AT LEAST ONE OPIATE ANTAGONIST FOR THE TREATMENT OF OPIATE DEPENDENCE AND FOR THE PREVENTION OF NON-ORAL OPIATE ABUSE IN OPIATE ADDICTS
WO2006049933A3 (en)Compositions and methods for the treatment of obesity and sexual dysfunction
NO20042758L (en) Procedure for treating a patient requiring analgesia.
AP2002002501A0 (en)Synergistic combinations of an NK1 receptor antagonist and a gaba structural analog.
WO2005082070A3 (en)Compositions and methods for the systemic treatment of arthritis
WO2000053148A3 (en)Methods and compositions for treating erectile dysfunction
WO2005107467A3 (en)Compositions including opioids and methods of their use in treating pain

Legal Events

DateCodeTitleDescription
AKDesignated states

Kind code of ref document:A2

Designated state(s):AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

ALDesignated countries for regional patents

Kind code of ref document:A2

Designated state(s):GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121Ep: the epo has been informed by wipo that ep was designated in this application
WWEWipo information: entry into national phase

Ref document number:2004281153

Country of ref document:AU

WWEWipo information: entry into national phase

Ref document number:2542395

Country of ref document:CA

Ref document number:2004795362

Country of ref document:EP

ENPEntry into the national phase

Ref document number:2004281153

Country of ref document:AU

Date of ref document:20041015

Kind code of ref document:A

WWPWipo information: published in national office

Ref document number:2004281153

Country of ref document:AU

WWPWipo information: published in national office

Ref document number:2004795362

Country of ref document:EP
[8]ページ先頭
©2009-2025 Movatter.jp